Home » Seegene Debuts Automated Development for Molecular Testing Devices
Seegene Debuts Automated Development for Molecular Testing Devices
Seegene has developed a in silico-based solution for automated development of molecular testing devices, the company revealed Wednesday.
The automated solution can reduce assay development time significantly, down to less than a week.
By using an in silico-based development solution, Seegene has found a way to simplify the process of real-time PCR assay development and is looking to expand its use in molecular diagnostics, the company disclosed. — Cynthia Jessup
Upcoming Events
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May